NDC 70518-1560 – Doxazosin
Doxazosin Mesylate 2 mg/1 · Tablet · Oral
Product NDC70518-1560
Product details
- Brand name
- Doxazosin
- Generic name
- Doxazosin
- Labeler
- REMEDYREPACK INC.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA202824
- Marketed since
- October 19, 2018
- Listing expires
- December 31, 2027
- Pharmacologic class
- alpha-Adrenergic Blocker
Active ingredients
- Doxazosin Mesylate 2 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 70518-1560-1 | 90 TABLET in 1 BOTTLE, PLASTIC (70518-1560-1) | Jul 14, 2020 |
Recalls mentioning this NDC
- D-0492-2023 Apr 12, 2023 · Class II
cGMP Deviations - D-1270-2019 May 8, 2019 · Class II
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 0.96 parts per million.
Other Doxazosin products
- 50090-8055 Doxazosin Mesylate 4 mg/1 · Tablet · A-S Medication Solutions
- 50090-2153 Doxazosin Mesylate 1 mg/1 · Tablet · A-S Medication Solutions
- 50090-3143 Doxazosin Mesylate 8 mg/1 · Tablet · A-S Medication Solutions
- 50090-7803 Doxazosin Mesylate 4 mg/1 · Tablet · A-S Medication Solutions
- 50090-6298 Doxazosin Mesylate 4 mg/1 · Tablet · A-S Medication Solutions
- 50090-2172 Doxazosin Mesylate 4 mg/1 · Tablet · A-S Medication Solutions
- 50090-5773 Doxazosin Mesylate 2 mg/1 · Tablet · A-S Medication Solutions
- 50090-0701 Doxazosin Mesylate 1 mg/1 · Tablet · A-S Medication Solutions
- 50090-0704 Doxazosin Mesylate 2 mg/1 · Tablet · A-S Medication Solutions
- 50090-3927 Doxazosin Mesylate 4 mg/1 · Tablet · A-S Medication Solutions
- 50090-6401 Doxazosin Mesylate 2 mg/1 · Tablet · A-S Medication Solutions
- 16729-211 Doxazosin Mesylate 1 mg/1 · Tablet · Accord Healthcare Inc.